Repligen 관리
관리 기준 확인 2/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Olivier Loeillot
최고 경영자
US$5.4m
총 보상
| CEO 급여 비율 | 2.5% |
| CEO 임기 | 1.1yrs |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | 1.8yrs |
| 이사회 평균 재임 기간 | 8.7yrs |
최근 관리 업데이트
Recent updates
Repligen Corporation's Earnings Preview: Expensive With Mixed Growth Prospects
Nov 12Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08
Is It Time To Consider Buying Repligen Corporation (NASDAQ:RGEN)?
Oct 14Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 28% Above Its Share Price
Sep 08Repligen Corporation (NASDAQ:RGEN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 31We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen: Strong Filtration Growth, Offset By Other Challenges
Jul 13Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge
Jun 14Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?
Jun 10Repligen Stock: Still Quite Overvalued
May 30Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models
May 03Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Apr 30Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?
Feb 13Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Jan 08Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price
Dec 19What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?
Nov 01Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?
Sep 29Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade
Aug 09Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?
Jul 03With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case
Jun 19CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$8m |
| Jun 30 2024 | n/a | n/a | US$9m |
| Mar 31 2024 | n/a | n/a | US$24m |
| Dec 31 2023 | US$5m | US$138k | US$36m |
보상 대 시장: Olivier 의 총 보상 ($USD 5.45M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 7.94M ).
보상과 수익: Olivier 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.
CEO
Olivier Loeillot (54 yo)
1.1yrs
테뉴어
US$5,445,065
보상
Mr. Olivier Loeillot is President of Repligen Corporation from October 02, 2023 & served as it's Chief Commercial Officer and serves as it's CEO & Director since September 1, 2024. Mr. Loeillot served a co...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Executive Chair | 9.5yrs | US$7.93m | 0.18% $ 14.2m | |
| President | 1.1yrs | US$5.45m | 데이터 없음 | |
| CFO & Chief Compliance Officer | 1.2yrs | US$2.03m | 데이터 없음 | |
| Chief Operating Officer | 4.7yrs | US$3.74m | 0.0075% $ 585.2k | |
| Senior Vice President of Research & Development | 8.1yrs | US$1.66m | 0.010% $ 798.4k | |
| Chief Information Officer | no data | 데이터 없음 | 데이터 없음 | |
| Global Head of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Global Head of Legal | no data | 데이터 없음 | 데이터 없음 | |
| VP & Global Head of Sales | 2.1yrs | 데이터 없음 | 데이터 없음 | |
| Senior Director of Marketing | less than a year | 데이터 없음 | 데이터 없음 | |
| Vice President of Human Resources | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Senior VP of Strategy and Business Development & Global Head of Bioprocess Analytics | 4.8yrs | 데이터 없음 | 데이터 없음 |
1.8yrs
평균 재임 기간
60yo
평균 연령
경험이 풍부한 관리: RGEN 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Executive Chair | 9.5yrs | US$7.93m | 0.18% $ 14.2m | |
| President | less than a year | US$5.45m | 데이터 없음 | |
| Independent Director | 9.1yrs | US$322.84k | 0.022% $ 1.7m | |
| Member of Scientific Advisory Board | 8.7yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 1.8yrs | US$453.50k | 0.0070% $ 544.7k | |
| Lead Independent Director | 19.2yrs | US$431.12k | 0.16% $ 12.6m | |
| Member of Scientific Advisory Board | 8.7yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board & Independent Director | 8.7yrs | US$282.84k | 0.00095% $ 73.9k | |
| Member of Scientific Advisory Board | 8.7yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 4.7yrs | US$287.84k | 0.0042% $ 326.1k | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 10.4yrs | US$307.84k | 0.0071% $ 551.0k |
8.7yrs
평균 재임 기간
64yo
평균 연령
경험이 풍부한 이사회: RGEN 의 이사회는 경험(평균 재직 기간 8.7 년)으로 간주됩니다.